Vivian Wong

2.4k total citations
32 papers, 1.8k citations indexed

About

Vivian Wong is a scholar working on Epidemiology, Complementary and alternative medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Vivian Wong has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Complementary and alternative medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Vivian Wong's work include Complementary and Alternative Medicine Studies (5 papers), COVID-19 Clinical Research Studies (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Vivian Wong is often cited by papers focused on Complementary and Alternative Medicine Studies (5 papers), COVID-19 Clinical Research Studies (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Vivian Wong collaborates with scholars based in Hong Kong, China and United States. Vivian Wong's co-authors include Jane C. Chan, Eva L. H. Tsui, George A. Bonanno, Samuel M. Y. Ho, Juliana C.N. Chan, S. T. Lai, Carolyn Tam, KH Chan, Maureen Mo-Lin Wong and Joseph J.�Y. Sung and has published in prestigious journals such as Annals of Internal Medicine, Diabetes Care and The Journal of Urology.

In The Last Decade

Vivian Wong

31 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vivian Wong Hong Kong 19 560 309 248 221 209 32 1.8k
Andrew I. Geller United States 19 193 0.3× 93 0.3× 124 0.5× 507 2.3× 219 1.0× 46 2.3k
Maria-Intí Metzendorf Germany 26 585 1.0× 449 1.5× 137 0.6× 319 1.4× 295 1.4× 112 3.5k
António Vaz Carneiro Portugal 27 203 0.4× 236 0.8× 61 0.2× 426 1.9× 190 0.9× 139 3.0k
Amir Vahedian‐Azimi Iran 24 159 0.3× 379 1.2× 45 0.2× 257 1.2× 154 0.7× 180 2.1k
Stefano Fumagalli Italy 25 208 0.4× 185 0.6× 176 0.7× 223 1.0× 165 0.8× 127 2.3k
Hyun‐Young Shin South Korea 15 402 0.7× 91 0.3× 25 0.1× 193 0.9× 143 0.7× 45 1.2k
Siti Setiati Indonesia 22 175 0.3× 80 0.3× 51 0.2× 126 0.6× 105 0.5× 138 1.7k
Swapna Mandal United Kingdom 24 614 1.1× 427 1.4× 39 0.2× 202 0.9× 746 3.6× 73 3.2k
Goverdhan Dutt Puri India 13 658 1.2× 211 0.7× 33 0.1× 153 0.7× 329 1.6× 71 1.3k
Katarzyna Kotfis Poland 26 547 1.0× 262 0.8× 31 0.1× 377 1.7× 635 3.0× 114 2.9k

Countries citing papers authored by Vivian Wong

Since Specialization
Citations

This map shows the geographic impact of Vivian Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivian Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivian Wong more than expected).

Fields of papers citing papers by Vivian Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivian Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivian Wong. The network helps show where Vivian Wong may publish in the future.

Co-authorship network of co-authors of Vivian Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Vivian Wong. A scholar is included among the top collaborators of Vivian Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivian Wong. Vivian Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wong, Vivian, et al.. (2022). Use of phosphodiesterase-5 inhibitors and the incidence of melanoma. Cancer Epidemiology. 81. 102251–102251. 4 indexed citations
3.
Wong, Vivian, et al.. (2021). Trends in Positioning for Robotic Prostatectomy: Results From a Survey of the Endourological Society. Cureus. 13(1). e12628–e12628. 1 indexed citations
4.
Wong, Vivian, et al.. (2020). Use of E-Cigarettes and Self-Reported Lung Disease Among US Adults. Public Health Reports. 135(6). 785–795. 7 indexed citations
5.
Wong, Vivian, et al.. (2020). MP27-08 URINARY EXOSOME TEST AND MP-MRI FOR PROSTATE CANCER SCREENING: BALANCING COSTS AND BENEFITS. The Journal of Urology. 203(Supplement 4). 1 indexed citations
6.
Jamieson, Scott, et al.. (2020). The Association Between Race and 5-year Survival in Patients With Clear Cell Renal Cell Carcinoma: A Cohort Study. Urology. 148. 185–191. 6 indexed citations
7.
Fan, Tai‐Ping, Daryl D. Rees, He Sun, et al.. (2012). Future development of global regulations of Chinese herbal products. Journal of Ethnopharmacology. 140(3). 568–586. 83 indexed citations
8.
Sui, Yi, Hai‐Lu Zhao, Vivian Wong, et al.. (2012). A systematic review on use of Chinese medicine and acupuncture for treatment of obesity. Obesity Reviews. 13(5). 409–430. 133 indexed citations
9.
Wu, Taixiang, Youping Li, Liang Du, et al.. (2011). Joint statement on promoting development of publication ethics among medical journals in China. Journal of Evidence-Based Medicine. 4(4). 214–216. 2 indexed citations
10.
Chung, Vincent CH, et al.. (2010). Using Chinese Version of MYMOP in Chinese Medicine Evaluation: Validity, Responsiveness and Minimally Important Change. Health and Quality of Life Outcomes. 8(1). 111–111. 8 indexed citations
11.
Woo, Jean, William B. Goggins, Xinhua Zhang, Siân M. Griffiths, & Vivian Wong. (2009). Aging and utilization of hospital services in Hong Kong: retrospective cohort study. Sozial- und Präventivmedizin. 55(3). 201–207. 3 indexed citations
12.
Yang, Xilin, Wing‐Yee So, Ronald C.W., et al.. (2008). Thresholds of risk factors for ischemic stroke in type 2 diabetic patients with and without albuminuria—A non-linear approach. Clinical Neurology and Neurosurgery. 110(7). 701–709. 7 indexed citations
13.
Bonanno, George A., et al.. (2008). Psychological resilience and dysfunction among hospitalized survivors of the SARS epidemic in Hong Kong: A latent class approach.. Health Psychology. 27(5). 659–667. 268 indexed citations
14.
Leung, Doris Y. P., Sophia Siu Chee Chan, Clara Bik‐San Lau, Vivian Wong, & TH Lam. (2008). An evaluation of the psychometric properties of the Smoking Self-Efficacy Questionnaire (SEQ-12) among Chinese cardiac patients who smoke. Nicotine & Tobacco Research. 10(8). 1311–1318. 26 indexed citations
15.
So, Wing Yee, Xilin Yang, Ronald C.W., et al.. (2007). Risk factors in V‐shaped risk associations with all‐cause mortality in type 2 diabetes—The Hong Kong Diabetes Registry. Diabetes/Metabolism Research and Reviews. 24(3). 238–246. 45 indexed citations
16.
Kung, A W, et al.. (2007). Changing epidemiology of osteoporotic hip fracture rates in Hong Kong. Archives of Osteoporosis. 2(1-2). 53–58. 15 indexed citations
17.
Yam, Loretta Yin-Chun, et al.. (2006). Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong. Journal of Infection. 54(1). 28–39. 80 indexed citations
18.
Yang, Xilin, Wing‐Yee So, Alice P.S. Kong, et al.. (2006). Development and Validation of Stroke Risk Equation for Hong Kong Chinese Patients With Type 2 Diabetes. Diabetes Care. 30(1). 65–70. 96 indexed citations
19.
20.
Cheung, Bmy, Dyt Fong, Vivian Wong, et al.. (2005). Randomised controlled trial of qigong in the treatment of mild essential hypertension. Journal of Human Hypertension. 19(9). 697–704. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew I. Geller Breakdown of academic impact, for papers by Maria-Intí Metzendorf Breakdown of academic impact, for papers by António Vaz Carneiro Breakdown of academic impact, for papers by Amir Vahedian‐Azimi Breakdown of academic impact, for papers by Stefano Fumagalli Breakdown of academic impact, for papers by Hyun‐Young Shin Breakdown of academic impact, for papers by Siti Setiati Breakdown of academic impact, for papers by Swapna Mandal Breakdown of academic impact, for papers by Goverdhan Dutt Puri Breakdown of academic impact, for papers by Katarzyna Kotfis
Rankless by CCL
2026